Avaleht › Lümfoom › Illinois › Chicago
Lümfoom kliinilised uuringud linnas Chicago, IL
20 uuringut haiguse Lümfoom jaoks otsivad osalejaid linnas Chicago ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
VärbamineFaas 2
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
VärbamineFaas 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
VärbamineFaas 3
- Research Site, Chicago
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
VärbamineFaas 1
- University of Illinois Cancer Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
VärbamineFaas 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
VärbamineFaas 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
VärbamineFaas 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
VärbamineFaas 3
- Northwestern, Chicago
- University of Chicago, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Värbamine
- Northwestern University Feinberg School of Medicine, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
VärbamineFaas 2
- Robert H Lurie Cancer Center, Chicago
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
VärbamineFaas 1/2
- Call for Information (Investigational Site 0024), Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- Northwestern University, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
VärbamineVaatlusuuring
- Lurie Children's Hospital-Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
VärbamineFaas 1/2
- Northwestern Memorial Hospital, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
VärbamineFaas 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- The University of Chicago Medical Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
VärbamineFaas 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Värbamine
- University of Chicago Comprehensive Cancer Center, Chicago
Avo In R/R And Previously Untreated MCL
VärbamineFaas 1/2
- University of Chicago Medical Center, Chicago
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
VärbamineFaas 1
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Lümfoom uuringud teistes linnades
- Houston, TX34 uuringut
- Boston, MA33 uuringut
- New York City, NY33 uuringut
- Washington, DC23 uuringut
- Baldwin Park, CA21 uuringut
- Durham, NC17 uuringut
- St. Louis, MO15 uuringut
- Philadelphia, PA15 uuringut
- Cleveland, OH14 uuringut
- Edison, NJ12 uuringut
- Atlanta, GA12 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Chicago
- Mitteväikerakuline kopsuvähk61 uuringut
- Rinnavähk58 uuringut
- Vähk (kõik liigid)51 uuringut
- Metastaatiline vähk45 uuringut
- Eesnäärmevähk45 uuringut
- Rasvumine41 uuringut
- Kopsuvähk41 uuringut
- Munasarjavähk36 uuringut
- Insult34 uuringut
- Käär- ja pärasoolevähk33 uuringut
- Südamepuudulikkus31 uuringut
- Ülekaalulisus28 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.